Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain

[at noodls] – SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, … more

View todays social media effects on ZGNX

View the latest stocks trending across Twitter. Click to view dashboard